3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
358
Precursor Cell Lymphoblastic Leukemia-Lymphoma
164
Leukemia
160
Lymphoma
109
Myelodysplastic Syndromes
74
Lymphoma, Non-Hodgkin
66
Lymphoma, Large B-Cell, Diffuse
61
Lymphoma, Mantle-Cell
59
Burkitt Lymphoma
58
Recurrence
56
Congenital Abnormalities
44
Leukemia, Monocytic, Acute
39
Lymphoma, Follicular
37
Hodgkin Disease
35
Leukemia, Myelomonocytic, Acute
34
Leukemia, Erythroblastic, Acute
34
Leukemia, Megakaryoblastic, Acute
32
Blast Crisis
29
Lymphoma, Large-Cell, Immunoblastic
27
Leukemia, Myelomonocytic, Chronic
26
Leukemia, Lymphocytic, Chronic, B-Cell
26
Leukemia, Biphenotypic, Acute
26
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
24
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
19
Lymphoma, B-Cell, Marginal Zone
19
Anemia, Refractory, with Excess of Blasts
19
Myeloproliferative Disorders
17
Lymphoma, B-Cell
17
Leukemia, Myeloid, Accelerated Phase
16
Neoplasm, Residual
15
Interventions
Cyclophosphamide
361
Trastuzumab
352
Paclitaxel
304
Docetaxel
272
Capecitabine
222
Letrozole
221
Carboplatin
185
Doxorubicin
181
Tamoxifen
157
Radiotherapy
154
Epirubicin
145
Fulvestrant
143
Anastrozole
139
Surveys and Questionnaires
133
Exercise
128
pertuzumab
113
Vinorelbine
110
Blood Specimen Collection
109
exemestane
106
palbociclib
104
Bevacizumab
104
pembrolizumab
98
Magnetic Resonance Spectroscopy
97
Albumin-Bound Paclitaxel
87
Gemcitabine
84
Drug Therapy
83
Lapatinib
78
130-nm albumin-bound paclitaxel
72
Neoadjuvant Therapy
71
Cisplatin
69
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Breast Neoplasms
×
Cytarabine
×
Clear all
NCT01645839
2019-06-12
DEPOSEIN
Centre Oscar Lambret
Phase 3
Completed
74 enrolled